
Keywords: AO; adverse outcome; AOP; adverse outcome pathway; BMD; benchmark dose modelling; BQE; biological quality element; CA; concentration addition; CAG; cumulative assessment group; CMEP; chemical monitoring and emerging pollutants; CRA; cumulative risk assess